Amgen-Backed Open Science Platform Targets Faster Peer Review
This article was originally published in Scrip
Executive Summary
An open science publishing platform offering biopharma scientists a low-barrier way to share their findings early has just been launched in an effort to reduce R&D wastage and reflect the fact science and research are becoming more transparent and collaborative.